This document provides guidance on key sections of an NIH R01 grant application, including Significance, Innovation, and review criteria. It discusses that Significance refers to how the project will advance scientific knowledge or improve clinical practice if successful, not just the importance of the disease topic. Reviewers evaluate the rigor of prior research supporting the project and the applicant's plans to address weaknesses. Innovation can involve novel concepts, approaches, technologies, or new applications of existing methods. The simplified NIH review framework focuses on whether the proposed research should be conducted based on Significance and Approach.
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
How to Craft the "Significance” & "Innovation" [Filler] - 2023UCLA CTSI
CTSI R Workshop: How to Craft the "Significance” & "Innovation" Sections of a Grant Application.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD, speaks on the topic of "How to Craft the "Significance” & "Innovation" Sections of a Grant Application" at the R Award Workshop on November 08, 2018 at UCLA.
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD, speaks on the topic of "How to Craft the "Significance” & "Innovation" Sections of a Grant Application" at the R Award Workshop on November 09, 2017 at UCLA.
What happens to your grant once it gets to a study section?
In this presentation, Dr. Paul Martin leverages his experience as a seasoned National Institutes of Health grant reviewer, including his tenure as Chair of the Cancer Immunopathology and Immunotherapy Study Section, to provide insight into the workings of NIH study sections.
Learn how to:
- Identify the fundamentals of grant review, including an overview of study sections and grant scoring;
- Determine differences between "impact" and "significance";
- Recognize effective strategies in writing and how to avoid frequent mistakes.
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
How to Craft the "Significance” & "Innovation" [Filler] - 2023UCLA CTSI
CTSI R Workshop: How to Craft the "Significance” & "Innovation" Sections of a Grant Application.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD, speaks on the topic of "How to Craft the "Significance” & "Innovation" Sections of a Grant Application" at the R Award Workshop on November 08, 2018 at UCLA.
How to Craft the "Significance” & "Innovation" Sections of a Grant Applicatio...UCLA CTSI
William Parks, PhD, speaks on the topic of "How to Craft the "Significance” & "Innovation" Sections of a Grant Application" at the R Award Workshop on November 09, 2017 at UCLA.
What happens to your grant once it gets to a study section?
In this presentation, Dr. Paul Martin leverages his experience as a seasoned National Institutes of Health grant reviewer, including his tenure as Chair of the Cancer Immunopathology and Immunotherapy Study Section, to provide insight into the workings of NIH study sections.
Learn how to:
- Identify the fundamentals of grant review, including an overview of study sections and grant scoring;
- Determine differences between "impact" and "significance";
- Recognize effective strategies in writing and how to avoid frequent mistakes.
RESEARCH METHODOLOGY FOR UNDERGRADUATES.pptxROBIN VAVACHAN
Embarking on the journey of research as undergraduates is both exciting and challenging. This presentation introduces the fundamental principles of research methodology, offering a roadmap for undergraduates to navigate the complexities of academic inquiry.
Advice from the Battleground: Inside NIH Study Sections and Common Mistakes o...SC CTSI at USC and CHLA
The purpose of this seminar was to provide practical guidance to investigators who are submitting grant applications, discuss how the sections are evaluated, and go over common mistakes to avoid during the application process. The seminar included a panel of five speakers led by a moderator.
What Next: When You are not Funded on the First Round - 2023UCLA CTSI
CTSI R Workshop: What Next: When You are not Funded on the First Round.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Write the “Specific Aims” Section - 2023UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application.
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
AssociateDirector, UCLA Specialty Training and Advanced Research (STAR) Program
More Related Content
Similar to How to Craft the "Significance” & "Innovation" - 2023
RESEARCH METHODOLOGY FOR UNDERGRADUATES.pptxROBIN VAVACHAN
Embarking on the journey of research as undergraduates is both exciting and challenging. This presentation introduces the fundamental principles of research methodology, offering a roadmap for undergraduates to navigate the complexities of academic inquiry.
Advice from the Battleground: Inside NIH Study Sections and Common Mistakes o...SC CTSI at USC and CHLA
The purpose of this seminar was to provide practical guidance to investigators who are submitting grant applications, discuss how the sections are evaluated, and go over common mistakes to avoid during the application process. The seminar included a panel of five speakers led by a moderator.
What Next: When You are not Funded on the First Round - 2023UCLA CTSI
CTSI R Workshop: What Next: When You are not Funded on the First Round.
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Write the “Specific Aims” Section - 2023UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application.
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
AssociateDirector, UCLA Specialty Training and Advanced Research (STAR) Program
How to Structure the “Approach” Section (Basic Science)UCLA CTSI
CTSI R Workshop: How to Structure the “Approach” Section of a Grant Application
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
A Tactical Approach to Writing Your Grant Application (HSR) - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application (HSR)
Tannaz Moin, MD, MBA, MSHS
Associate Professor of Medicine at UCLA
Associate Director, UCLA Specialty Training and Advanced Research (STAR) Program
A Tactical Approach to Writing Your Grant Application - 2023UCLA CTSI
CTSI R Workshop: A Tactical Approach to Writing Your Grant Application
William Parks, PhD
Professor of Medicine at Cedars-Sinai Medical Center and UCLA
Associate Dean for Graduate Research Education
Scientific Director, Women’s Guild Lung Institute
How to Write the “Specific Aims” Section of a Grant Application (Basic Scienc...UCLA CTSI
CTSI R Workshop: How to Write the “Specific Aims” Section of a Grant Application (Basic Science
Scott G. Filler, MD
Professor of Medicine at Lundquist Institute/Harbor-UCLA and UCLA
Leader, CTSI Pilot Translational and Clinical Studies Program
Co-Leader, CTSI KL2 Institutional Development Core
How to Anticipate and Plan for an R Grant Application - 2023UCLA CTSI
CTSI R Workshop: How to Anticipate and Plan for an R Grant Application.
Presented by Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Leader, UCLA CTSI Workforce Development
NIH Loan Repayment Program (LRP) Info Session - 9/26/23UCLA CTSI
The UCLA CTSI and DGSOM Office of Physician Scientist Career Development held this webinar to provide information on the NIH Loan Repayment Program (LRP). This funding is designed to recruit and retain highly qualified health professionals into biomedical or biobehavioral research careers. The LRPs counteract financial pressure by repaying up to $50,000 annually of a researcher's qualified educational debt in return for a commitment to engage in NIH mission-relevant research.
Writing the NIH K Award – Research Plan
Presented by
Sumeet S. Chugh, MD
Price Professor and Associate Director, Smidt Heart Institute
Director, Division of Artificial Intelligence in Medicine
Cedars-Sinai Medical Center
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"...UCLA CTSI
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence"
Presented by Christopher Evans, PhD
Professor of Psychiatry and Biobehavioral Sciences at UCLA
Co-Director, UCLA CTSI KL2 Program
Navigating the NIH K Award Process and Choosing Your Mentorship Team (2023)UCLA CTSI
Navigating the NIH K Award Process and Choosing Your Mentorship Team
Presented by
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Professor of Medicine and Public Health at UCLA
Chief, Division of General Internal Medicine and Health Services Research
Leader, UCLA CTSI Workforce Development
K Awards – Common Pitfalls and UCLA CTSI KL2 Resources (2023)UCLA CTSI
K Awards – Common Pitfalls and UCLA CTSI KL2 Resources
Presented by Elizabeta Nemeth, PhD
Professor of Medicine at UCLA
Director, UCLA Center for Iron Disorders
Co-Director, UCLA CTSI KL2 Program
Writing the NIH K Award – Candidate Information and Career Development Plan, ...UCLA CTSI
Writing the NIH K Award – Candidate Information and Career Development Plan,
How Reviewers Evaluate K Awards, and Common Critiques from NIH K Study Sections
Presented by O. Kenrik Duru, MD, MSHS
Professor of Medicine at UCLA
Investigator (Disparities), UCLA CTSI Special Populations
How to Anticipate and Plan for an R Grant Application. (2022)UCLA CTSI
Carol M. Mangione, MD, MSPH
Barbara A. Levey MD & Gerald S. Levey MD Endowed Chair
Chief, Division of General Internal Medicine and Health Services Research
Professor of Medicine and Public Health at UCLA
Leader, UCLA CTSI Workforce Development
K99 Award: the NIH "Pathway to Independence"UCLA CTSI
UCLA CTSI K Workshop - July 28, 2022
Considerations in Applying for a K99 Award: the NIH "Pathway to Independence" presented by Dr. Christopher Evans, PhD
UCLA CTSI KL2 Resources
Presented by Mitchell D. Wong, MD, PhD
Professor of Medicine at UCLA
Executive Co-Director, Specialty Training and Advanced Research (STAR) Program
Director, UCLA CTSI KL2 Program
Students, digital devices and success - Andreas Schleicher - 27 May 2024..pptxEduSkills OECD
Andreas Schleicher presents at the OECD webinar ‘Digital devices in schools: detrimental distraction or secret to success?’ on 27 May 2024. The presentation was based on findings from PISA 2022 results and the webinar helped launch the PISA in Focus ‘Managing screen time: How to protect and equip students against distraction’ https://www.oecd-ilibrary.org/education/managing-screen-time_7c225af4-en and the OECD Education Policy Perspective ‘Students, digital devices and success’ can be found here - https://oe.cd/il/5yV
2024.06.01 Introducing a competency framework for languag learning materials ...Sandy Millin
http://sandymillin.wordpress.com/iateflwebinar2024
Published classroom materials form the basis of syllabuses, drive teacher professional development, and have a potentially huge influence on learners, teachers and education systems. All teachers also create their own materials, whether a few sentences on a blackboard, a highly-structured fully-realised online course, or anything in between. Despite this, the knowledge and skills needed to create effective language learning materials are rarely part of teacher training, and are mostly learnt by trial and error.
Knowledge and skills frameworks, generally called competency frameworks, for ELT teachers, trainers and managers have existed for a few years now. However, until I created one for my MA dissertation, there wasn’t one drawing together what we need to know and do to be able to effectively produce language learning materials.
This webinar will introduce you to my framework, highlighting the key competencies I identified from my research. It will also show how anybody involved in language teaching (any language, not just English!), teacher training, managing schools or developing language learning materials can benefit from using the framework.
Model Attribute Check Company Auto PropertyCeline George
In Odoo, the multi-company feature allows you to manage multiple companies within a single Odoo database instance. Each company can have its own configurations while still sharing common resources such as products, customers, and suppliers.
How to Make a Field invisible in Odoo 17Celine George
It is possible to hide or invisible some fields in odoo. Commonly using “invisible” attribute in the field definition to invisible the fields. This slide will show how to make a field invisible in odoo 17.
Welcome to TechSoup New Member Orientation and Q&A (May 2024).pdfTechSoup
In this webinar you will learn how your organization can access TechSoup's wide variety of product discount and donation programs. From hardware to software, we'll give you a tour of the tools available to help your nonprofit with productivity, collaboration, financial management, donor tracking, security, and more.
This is a presentation by Dada Robert in a Your Skill Boost masterclass organised by the Excellence Foundation for South Sudan (EFSS) on Saturday, the 25th and Sunday, the 26th of May 2024.
He discussed the concept of quality improvement, emphasizing its applicability to various aspects of life, including personal, project, and program improvements. He defined quality as doing the right thing at the right time in the right way to achieve the best possible results and discussed the concept of the "gap" between what we know and what we do, and how this gap represents the areas we need to improve. He explained the scientific approach to quality improvement, which involves systematic performance analysis, testing and learning, and implementing change ideas. He also highlighted the importance of client focus and a team approach to quality improvement.
Unit 8 - Information and Communication Technology (Paper I).pdfThiyagu K
This slides describes the basic concepts of ICT, basics of Email, Emerging Technology and Digital Initiatives in Education. This presentations aligns with the UGC Paper I syllabus.
Ethnobotany and Ethnopharmacology:
Ethnobotany in herbal drug evaluation,
Impact of Ethnobotany in traditional medicine,
New development in herbals,
Bio-prospecting tools for drug discovery,
Role of Ethnopharmacology in drug evaluation,
Reverse Pharmacology.
The Art Pastor's Guide to Sabbath | Steve ThomasonSteve Thomason
What is the purpose of the Sabbath Law in the Torah. It is interesting to compare how the context of the law shifts from Exodus to Deuteronomy. Who gets to rest, and why?
2. R01 Grant Sections
• Face Page
• Table of Contents
• Performance Site
• Project Description: Abstract
• Project Narrative: 2 sentences
• References Cited
• Facilities and Other Resources
• Equipment
• Key Personnel
• Biosketches
• Budget (all years)
• Budget Justification
• Introduction
(resubmission only)
• Specific Aims
• Research Strategy
• Significance
• Innovation
• Approach
• Protection of Human Subjects
• Women & Minorities
• Planned Enrollment Table
• Children
• Vertebrate Animals
• Select Agents
• Multiple PI Plan
• Letters of Support
• Resource Sharing
• Authentication of Key
Biological and/or Chemical
Resources
• PHS Assignment Form
3. Scored Review Criteria
Investigator Initiated
R-series Grants
• Significance
• Investigator
• Approach
• Innovation
• Environment
Overall
Impact
Overall Impact or
Criterion Strength
Score Descriptor
High
1 Exceptional
2 Outstanding
3 Excellent
Moderate
4 Very Good
5 Good
6 Satisfactory
Low
7 Fair
8 Marginal
9 Poor
• Criterion Score
• Whole numbers: 1-9
• 1 (exceptional); 9 (well let’s just hope you never get a 9)
• Given by reviewers but not discussed at study section
• Provided in Summary Statement of all applications
• Overall Impact Score
• Not the mean of the criteria scores
• Different criteria are weighted by each reviewer
• Final Impact Score, Percentile
• Mean of all scores x 10 ➤ 10 – 90
• Percentiled against R01s applications across 3 meetings
4. New ‘Simplified’ Review Framework
• January 2025
• https://grants.nih.gov/policy/peer/simplifying-review.htm
• "Should the proposed research project be conducted?”
• Significance
• Approach
6. Innovation
• Does the application challenge and seek to shift current research or
clinical practice paradigms by utilizing novel theoretical concepts,
approaches or methodologies, instrumentation, or interventions?
• Are the concepts, approaches or methodologies, instrumentation, or
interventions novel to one field of research or novel in a broad
sense?
• Is a refinement, improvement, or new application of theoretical
concepts, approaches or methodologies, instrumentation, or
interventions proposed?
Current Instructions to Reviewers
7. Innovation
• Two flavors
1. New concepts or challenges to existing paradigms or dogma
2. New reagents, assays, technologies, etc.
• However, “proposals do not need to be innovative”
• Thus, not a major review criteria – but can be a big plus
• Not mentioned in instructions to reviewers for K applications
9. Innovation
• Keep it short
• 1-2 paragraphs
• Bulleted list
• Be realistic
Our data will provide new information on how specific functions of macrophages
are regulated. Conceptually, our project will demonstrate that macrophages are not
necessarily bad players in fibrosis and furthers the idea, which we were among the
first to propose, that MMPs function primarily to affect the behavior of immune cells.
11. Significance
• Does the project address an important problem or a critical barrier to
progress in the field?
• Is the prior research that serves as the key support for the proposed
project rigorous?
• If the aims of the project are achieved, how will scientific knowledge,
technical capability, and/or clinical practice be improved?
• How will successful completion of the aims change the concepts,
methods, technologies, treatments, services, or preventative interventions
that drive this field?
Instructions to Reviewers
12. What is Significance and How is it Evaluated?
• Not related to the disease or cellular process you are studying
• After all, all diseases are significant
• Basic science research can have an impact
• Rather, if the aims are achieved, will scientific knowledge, technical
capability, and/or clinical practice be improved?
• Hence, Research Approach impacts Significance
• A wet-lab proposal that is descriptive or derivative or will gather
correlative information will not be significant
- Epidemiology or clinical studies may seek associative findings
• Evaluation of and attention to rigor
13. Common Misconception
• Significance only means translational science, clinical importance, and/or
disease related
• Not true: basic research can have a great an impact
• “NIH’s mission is to seek fundamental knowledge about the nature and
behavior of living systems and the application of that knowledge to
enhance health, lengthen life, and reduce illness and disability.”
• An application does not need to show the potential for clinical impact
• You do not need to develop a new drug!
14. • Describe the strengths and weaknesses/gaps in the rigor of the prior research (published
and unpublished) that serves as the key support for the proposed project and plans to
address weaknesses/gaps.
• Rigor: Strict application of the scientific method to ensure robust and unbiased
experimental design, methodology, analysis, interpretation, and reporting of results.
• Variables: sample size, sex, age, weight, health condition, etc.
• Must address sex (approach)
• Authentication of key biological and/or chemical resources (1 page)
• Rigor is addressed by reviewers under both Significance (previous) and Approach
(planned)
• https://grants.nih.gov/grants/peer/guidelines_general/Reviewer_Guidance_on_Rigor_and_Transparency.pdf
• https://grants.nih.gov/grants/guide/notice-files/NOT-OD-18-228.html
Significance – Rigor of Previous Work, Yours and Others
15.
16. 1. Discuss the rigor of the research and data – both yours and
others – that form the foundation of your project.
2. Discuss how will you address any weaknesses pointed out in #1.
3. Include strategies that assure a lack of bias and an overall robust
approach.
4. Address relevant variables, especially sex.
How to Address Rigor in the Research Strategy
Significance
Approach
17. Significance (Background)
• 1-1.5 pages
• Critically review the literature and provide a clear
premise
• No limit on number of citations
• Original, timely papers over reviews
• Rigor: Point out gaps and flaws; strengths, too
• Do not be afraid to say you disagree with something
(but explain why and how you will correct this travesty)
• Be diplomatic
• Limit discussion to things (pathways, diseases, molecules, etc.)
you will study
• Show (tempered) enthusiasm
• Know your audience
• Get the reviewers interested
Pet Peeves
• Needlessly long
• Not focused
• Not timely nor scholarly
• Reliance on reviews
• Uses the word “exciting” more than
once
• Poorly developed premise
• Does not address rigor
18. Overall Impact vs. Significance
Overall Impact
• Likelihood of making a sustained,
powerful influence on the field
• Integrates the 5 scored criteria
• Not the mean of the 5 criteria
Significance
• Focus on relevance and likelihood
of making a meaningful advance if
the aims are achieved.
• Addresses an important problem or
critical barrier to progress
• Topic ≠ Significance